African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase
Open Access
- 1 December 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 141, 676-689
Abstract
No abstract availableKeywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/L017180/1)
- Novartis Institute for Tropical Diseases
This publication has 33 references indexed in Scilit:
- Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)The Lancet Neurology, 2013
- High-throughput decoding of antitrypanosomal drug efficacy and resistanceNature, 2012
- Purification and kinetic characterization of recombinant alternative oxidase from Trypanosoma brucei bruceiBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Crystallization and preliminary crystallographic analysis of cyanide-insensitive alternative oxidase fromTrypanosoma brucei bruceiActa Crystallographica Section F Structural Biology and Crystallization Communications, 2010
- Antigenic variation in the African trypanosome: molecular mechanisms and phenotypic complexityCellular Microbiology, 2009
- The Burden of Human African TrypanosomiasisPLOS Neglected Tropical Diseases, 2008
- ALTERNATIVE OXIDASE: From Gene to FunctionAnnual Review of Plant Biology, 1997
- Erratum to ``An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei''Molecular and Biochemical Parasitology, 1997
- Total syntheses of fungal metabolites and functionalized furanonesThe Journal of Organic Chemistry, 1985
- Acquired Resistance to ‘Melarsen’, Tryparsamide and Amidines in Pathogenic Trypanosomes after Treatment with ‘Melarsen’ AloneNature, 1951